Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy: Discrete Pulmonary Lesions and Acute Rejection in Transplanted Lungs
The primary aim of this study is to develop the criteria to differentiate healthy versus
diseased tissue in patient with discrete lung lesions or to characterize acute lung
rejection in patients with transplanted lungs. Once these criteria have been defined, the
diagnostic parameters and the reproducibility of pCLE will be assessed.
Observational Model: Cohort, Time Perspective: Prospective
Development of criteria for the characterization of discrete lung lesions and for characterization of acute lung rejection in lung transplant.
Up to 12 months
Cesar Keller, MD
Mayo Clinic - Jacksonville, FL
United States: Food and Drug Administration
|University of Michigan||Ann Arbor, Michigan 48109-0624|
|Mayo Clinic||Jacksonville, Florida 32224|
|Ohio State University||Columbus, Ohio 43210|
|University of Chicago||Chicago, Illinois 60637|